Vaccine News and Research

Latest Vaccine News and Research

Researchers identify protein linked to negative effects of senescence

Cellular senescence is a state in which normal healthy cells do not have the ability to divide. Senescence can occur when cancer-causing genes are activated in normal cells or when chemotherapy is used on cancer cells.

1 Nov 2016

Scientists discover how MEK inhibitor boosts antitumor activity and slows cancer progression

Understanding the effects of certain targeted therapies on antitumor immunity is necessary to design combined interventions for more effective cancer treatment.

1 Nov 2016

Dengue vaccinations could increase incidence of Zika virus, research finds

Vaccinating against dengue fever could increase outbreaks of Zika, suggests new research out of York University and Xi'an Jiaotong University in China.

31 Oct 2016

Study estimates prevalence of self-reported immunosuppressed adults in the U.S.

In a study published online by JAMA, Rafael Harpaz, M.D., M.P.H., of the U.S. Centers for Disease Control and Prevention, Atlanta, and colleagues analyzed data from the 2013 National Health Interview Survey to estimate the prevalence of self-reported immunosuppressed adults in the United States.

31 Oct 2016

Measles complication that kills children more common than previously thought

A complication of measles that kills children years after they have the infection is more common than thought, according to a study being presented at IDWeek 2016.

31 Oct 2016

Haiti’s Ministry of Health takes action to control cholera in areas affected by Hurricane Matthew

The Haitian Ministry of Health (MSPP) is setting up a vaccination campaign against cholera in areas ravaged by Hurricane Matthew, with support from the Pan American Health Organization / World Health Organization (PAHO / WHO).

31 Oct 2016

Neonatal vaccination of mice with bacteria prevents cockroach-induced asthma as adults

The hygiene hypothesis proposes that a 20th century surge in allergies and asthma is because people are living in increasingly hygienic environments.

27 Oct 2016

Neutralizing antibodies from Ebola survivors can protect mice against deadly viral challenge

A study by scientists at the Emory Vaccine Center, in collaboration with the biotechnology company Atreca, Inc., has found that antibodies generated from the blood of survivors of Ebola virus disease can strongly neutralize the Ebola virus in the laboratory and protect mice from a lethal viral challenge.

26 Oct 2016

Scientists discover potential new target for protective vaccines against Chagas disease

Saint Louis University Center for Vaccine Development researchers have identified a potential new target for vaccines that activates a part of the immune system not previously known to be protective against Chagas disease, tuberculosis and AIDS, as well as other diseases.

25 Oct 2016

ESCMID Study Group for Vaccines calls on all pregnant women to sign up for flu vaccine

The flu season is almost here and The European Society of Clinical Microbiology and Infectious Disease (ESCMID) and its specialist vaccine study group, the ESCMID Study Group for Vaccines (EVASG) is calling on all pregnant women to sign up for their flu vaccine.

25 Oct 2016

MTPConnect to provide $7.4 million funding for 14 national projects in medtech, biotech and pharmaceutical sector

MTPConnect - the Medical Technologies and Pharmaceuticals Industry Growth Centre - today announced it will provide $7.4 million of funding over two years for 14 national projects in the medtech, biotech and pharmaceutical (MTP) sector.

25 Oct 2016

Rabies vaccine stored at warmer temperatures can protect against disease, WSU research shows

A Washington State University-led research team determined rabies vaccines stored at warmer temperatures still protect against the disease in dogs.

24 Oct 2016

New approach could overcome large immunosuppressive tumors

Harnessing the body's own immune system to destroy tumors is a tantalizing prospect that has yet to realize its full potential. However, a new advance from MIT may bring this strategy, known as cancer immunotherapy, closer to becoming reality.

24 Oct 2016

TSRI scientists discover reason for lack of successful HCV vaccine design

Researchers have been trying for decades to develop a vaccine against the globally endemic hepatitis C virus (HCV). Now scientists at The Scripps Research Institute have discovered one reason why success has so far been elusive.

24 Oct 2016

Novel approach could help counter Influenza A virus in immune-compromised patients

To infect its victims, influenza A heads for the lungs, where it latches onto sialic acid on the surface of cells.

24 Oct 2016

Novel ‘gene therapy in a box’ could effectively deliver modified blood stem cells

A table-top device that enables medical staff to genetically manipulate a patient's blood to deliver potential new therapies for cancer, HIV and other diseases would eliminate the need for multi-million-dollar "clean rooms," making gene therapy more possible for even the poorest of countries.

24 Oct 2016

Scientists discover new mechanism for inadequate immune defense against chronic viral infection

Scientists at the University of Basel discovered a fundamental new mechanism explaining the inadequate immune defense against chronic viral infection. These results may open up new avenues for vaccine development. They have been published in the journal "Science Immunology".

21 Oct 2016

RIT faculty-researcher receives grant to help design coordinated vaccine procurement system

Rochester Institute of Technology received a three-year, $374,949 grant from the Bill & Melinda Gates Foundation for faculty-researcher Rubén Proaño to study and help design a coordinated decision-support system for the global procurement of vaccines.

21 Oct 2016

Study sheds new insights on immune cells involved in fighting dengue virus infection

India suffers from the highest number of dengue infections in the world, but there are few studies, if any, to understand the immune cells involved in fighting the virus.

21 Oct 2016

Preteens only need two HPV vaccines, not three, says immunization advisory panel

Preteens who have not yet received their human papilloma virus (HPV) vaccines only need to have two vaccines rather than three, say federal government advisers.

20 Oct 2016

Vaccine News and Research

Latest Vaccine News and Research

Researchers identify protein linked to negative effects of senescence

Scientists discover how MEK inhibitor boosts antitumor activity and slows cancer progression

Dengue vaccinations could increase incidence of Zika virus, research finds

Study estimates prevalence of self-reported immunosuppressed adults in the U.S.

Measles complication that kills children more common than previously thought

Haiti’s Ministry of Health takes action to control cholera in areas affected by Hurricane Matthew

Neonatal vaccination of mice with bacteria prevents cockroach-induced asthma as adults

Neutralizing antibodies from Ebola survivors can protect mice against deadly viral challenge

Scientists discover potential new target for protective vaccines against Chagas disease

ESCMID Study Group for Vaccines calls on all pregnant women to sign up for flu vaccine

MTPConnect to provide $7.4 million funding for 14 national projects in medtech, biotech and pharmaceutical sector

Rabies vaccine stored at warmer temperatures can protect against disease, WSU research shows

New approach could overcome large immunosuppressive tumors

TSRI scientists discover reason for lack of successful HCV vaccine design

Novel approach could help counter Influenza A virus in immune-compromised patients

Novel ‘gene therapy in a box’ could effectively deliver modified blood stem cells

Scientists discover new mechanism for inadequate immune defense against chronic viral infection

RIT faculty-researcher receives grant to help design coordinated vaccine procurement system

Study sheds new insights on immune cells involved in fighting dengue virus infection

Preteens only need two HPV vaccines, not three, says immunization advisory panel

Event guide: 3rd mRNA Process Development & Manufacturing Europe eBook

Unlocking drug amorphization: Continuous, solvent-free twin screw granulation

How can super-resolution technology help study neurotransmission?

The Proteoform Puzzle: Unlocking the Next Frontier

Vaccine News and Research

Latest Vaccine News and Research

Event guide: 3rd mRNA Process Development & Manufacturing Europe eBook

Unlocking drug amorphization: Continuous, solvent-free twin screw granulation

How can super-resolution technology help study neurotransmission?

The Proteoform Puzzle: Unlocking the Next Frontier

Newsletters you may be interested in